10-QPeriod: Q2 FY2002

Elevance Health, Inc. Quarterly Report for Q2 Ended Jun 30, 2002

Filed August 5, 2002For Securities:ELV

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) reported solid financial results for the second quarter and first half of 2002. The company demonstrated significant revenue growth, driven by premium increases and membership expansion across its various segments. Net income also saw a substantial increase year-over-year, reflecting improved operational performance and the positive impact of adopting new accounting standards. The acquisition of Trigon Healthcare, Inc. in July 2002 is a major strategic development, expected to expand the company's geographic reach and create further economies of scale, though it will also bring integration challenges and significant goodwill to the balance sheet. Key financial highlights include a 13% increase in total operating revenue for the three months ended June 30, 2002, compared to the prior year, and a 44% increase in net income for the six-month period. Membership grew by 7% year-over-year, indicating successful market penetration and retention strategies. The company also continues to manage its cost of care effectively, with benefit expense growing at a rate slightly lower than revenue, and has taken steps to control administrative expenses. Investors should note the significant impact of acquisitions, particularly Trigon, on future financial statements and the ongoing management of healthcare cost trends and regulatory environments.

Key Highlights

  • 1Total operating revenue increased by 13% to $2.84 billion for the three months ended June 30, 2002, compared to the prior year period.
  • 2Net income grew significantly, by 47% to $106.2 million for the three months ended June 30, 2002, and by 44% to $206.0 million for the six months ended June 30, 2002.
  • 3Total membership increased by 7% to 8.32 million as of June 30, 2002, driven by growth in National Accounts and Individual businesses.
  • 4The company completed the significant acquisition of Trigon Healthcare, Inc. on July 31, 2002, for approximately $4.2 billion, which is expected to expand its geographic footprint.
  • 5Benefit expense as a percentage of premiums (benefit ratio) improved to 83.6% for the three months ended June 30, 2002, down from 85.2% in the prior year.
  • 6The adoption of FAS 142 (Goodwill and Other Intangible Assets) on January 1, 2002, eliminated goodwill amortization, positively impacting reported net income and earnings per share.
  • 7The company maintains a strong liquidity position with $665.7 million in cash and cash equivalents as of June 30, 2002, and substantial unused credit facilities.

Frequently Asked Questions

The primary driver of revenue growth is an increase in premiums, fueled by both premium rate increases across various business segments (averaging 14% for Local Large Group and Small Group) and higher membership across all segments. For the three months ended June 30, 2002, premiums increased by 14% compared to the prior year.

The adoption of FAS 142 on January 1, 2002, eliminated the amortization of goodwill and certain other intangible assets. This accounting change positively impacted net income, as demonstrated in the 'Adjusted net income' and 'Adjusted earnings per share' tables, by removing prior amortization expenses that were previously recognized.

The acquisition of Trigon Healthcare, Inc., completed on July 31, 2002, for approximately $4.2 billion, is a major strategic move that will significantly expand Elevance Health's (then Anthem, Inc.) geographic presence, particularly in Virginia, creating a new 'Anthem Southeast' segment. It is expected to provide further economies of scale and contribute to future growth, though it will also result in a substantial increase in goodwill on the balance sheet.

The company is managing cost of care trends, which averaged approximately 13% for the twelve months ended June 30, 2002. Key drivers include increasing outpatient utilization and higher prescription drug costs (averaging 18% increase). While inpatient cost growth has slowed, hospital unit costs are rising due to contract renegotiations. The company is addressing these through various cost management strategies, including three-tiered drug programs and provider contract negotiations.